Even though the HPV vaccine is the only chance to prevent Human papillomavirus, it could also be a chance to prevent HIV infection. Nearly 37 HPV types have been found to be directly linked to HIV infection so far in this study.
Nearly Thirty-seven human papillomavirus (HPV) types have been found to be directly associated with human immunodeficiency virus (HIV) infection. The results of this study are published in the journal of PLOS ONE. The findings showed that a person with any HPV type, more than one HPV type, or high-risk HPV are more likely to test positive for HIV.
‘This study is in favor of taking the HPV vaccine, and not just to prevent HPV, but to prevent HIV also.’
Read More..
"Although most studies have shown a general link between HPV and HIV co-infection, our findings illustrate the strong relationship between individual HPV types and HIV infection," said lead author Brandon Brown, Associate Professor at the University of California, Riverside. Read More..
"Some HPV types are more linked to cancer and others to warts. This further illustrates the potential utility of HPV vaccine for men who have sex with men and trans women, not only for HPV prevention but also possibly for HIV prevention," Brown added.
Brown explained that previous research has shown that HPV, in general, was linked to HIV infection, but his research team looked at infection with 37 HPV types and found that individual types are linked, "which is more specific than saying HPV is linked."
The study, published in the journal PLOS ONE, identified HPV types such as HPV16, 18, 31, 33, 35, 52, 58, linked to HIV.
For the study, the team investigated nearly 600 men who have sex with men, or MSM, and transgender women in Lima, Peru.
Advertisement
Of the 571 participants who completed at least two study visits, 73 acquired HIV in two years -- a 6 percent HIV incidence rate.
Advertisement
Regarding prevention and treatment, Brown recommends the HPV vaccine, widely provided to everyone regardless of sex, gender, or sexual orientation before sexual debut, and for genital wart treatment.
"Even if the vaccine is not provided before sexual debut, there can be a strong benefit if given at any time to prevent HPV-associated disease and also HIV," he said.
"We know that HPV is the most common STI, and we know that HPV vaccine works to prevent chronic HPV infection. What we need now is to implement the vaccine in a better way. The availability in many other developing countries is low at best and absent at worst."
Source-Eurekalert